|
KIAA0586 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.64519999740409E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02729999454476E-08 |
| Normal-vs-Stage2 |
2.156700E-03 |
| Normal-vs-Stage3 |
5.012100E-04 |
| Normal-vs-Stage4 |
4.26119999996644E-06 |
| Stage1-vs-Stage2 |
7.690200E-01 |
| Stage1-vs-Stage3 |
4.998400E-01 |
| Stage1-vs-Stage4 |
3.708400E-01 |
| Stage2-vs-Stage3 |
8.021200E-01 |
| Stage2-vs-Stage4 |
3.030600E-01 |
| Stage3-vs-Stage4 |
1.786410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.84370000272583E-08 |
| Normal-vs-AfricanAmerican |
6.05300000011688E-07 |
| Normal-vs-Asian |
6.551100E-04 |
| Caucasian-vs-AfricanAmerican |
7.947400E-01 |
| Caucasian-vs-Asian |
6.263800E-01 |
| AfricanAmerican-vs-Asian |
6.756400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70449998559974E-09 |
| Normal-vs-Female |
7.939700E-03 |
| Male-vs-Female |
5.015200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62015999999321E-05 |
| Normal-vs-Extreme_Weight |
6.09009997987187E-09 |
| Normal-vs-Obese |
5.240100E-04 |
| Normal-vs-Extreme_Obese |
9.97169999999992E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.522200E-01 |
| Normal_Weight-vs-Obese |
1.981350E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.867200E-01 |
| Extreme_Weight-vs-Obese |
1.691720E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.696000E-01 |
| Obese-vs-Extreme_Obese |
2.417400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.729500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.15470000000762E-06 |
| Normal-vs-Age(61-80Yrs) |
5.08380004760056E-09 |
| Normal-vs-Age(81-100Yrs) |
3.55019999953576E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.905600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.261000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.791900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.059700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.302500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.578200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87699999987245E-08 |
| Normal-VS-Type2 PRCC |
2.39140000024562E-07 |
| Normal-VS-KIRP CIMP |
3.731200E-01 |
| Normal-VS-Unclassified PRCC |
1.037680E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.197800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.214200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.280770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.976440E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.785160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.088400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85959999621232E-08 |
| Normal-vs-N1 |
1.862350E-02 |
| Normal-vs-N2 |
9.90849999999988E-05 |
| N0-vs-N1 |
5.092400E-02 |
| N0-vs-N2 |
3.336200E-01 |
| N1-vs-N2 |
1.258360E-01 |
|
|
